Direct-to-consumer advertising: Should there be a free market in health care information

Hasman, Andreas and Holm, Søren 2006. Direct-to-consumer advertising: Should there be a free market in health care information. Cambridge Quarterly of Healthcare Ethics 15 (1) , pp. 42-49. 10.1017/S0963180106060051

Preview

PDF - Published Version Download (65kB) | Preview

Abstract

On June 3, 2003, the European Council of health ministers rejected a proposal from the European Commission to allow drug manufacturers to advertise directly to particular groups of patients; the proposal had already been rejected by the European Parliament subsequent to a heated public debate in which consumer and patient groups almost unanimously argued that it was not the role of drug companies to provide information to patients. The pilot scheme suggested by the Commission would only have applied to patients with three chronic diseases, AIDS, diabetes, and asthma, and would, it was argued, not undermine an overall ban. Drug companies would have been required to abide by a special code of conduct and clear any information given to patients—on web sites or in specialized publications—with national authorities.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Law
Subjects:	K Law > K Law (General) R Medicine > RA Public aspects of medicine
Additional Information:	Pdf uploaded in accordance with publisher's policy at http://www.sherpa.ac.uk/romeo/issn/0963-1801/ (accessed 21/02/2014).
Publisher:	Cambridge University Press
ISSN:	0963-1801
Date of First Compliant Deposit:	30 March 2016
Last Modified:	06 May 2023 03:45
URI:	https://orca.cardiff.ac.uk/id/eprint/47693

Citation Data

Cited 9 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item